Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
26 hedge funds and large institutions have $541M invested in Odonate Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$288M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$64.4M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$37.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.1M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$19.5M |
Top Sellers
ODT Hedge Fund Activity: Q4 2017 in Review
26 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q4 2017, worth a combined $541M.
Buyers outnumbered sellers: 26 funds opened new ODT positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $288M.
- 26 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q4 2017, up from 0 in Q3 2017.
- Funds reported $541M of Odonate Therapeutics, Inc. Common Stock stock for Q4 2017.
- 26 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +26 holders.
- The largest Odonate Therapeutics, Inc. Common Stock buyer in Q4 2017 was Tang Capital Management, an estimated $288M added.
Based on aggregated 13F filings for Q4 2017.